ImageneBio (IMA) Short-term Investments (2022 - 2025)
ImageneBio (IMA) posted Short-term Investments of $40.8 million for Q4 2025, up 3.54% sequentially from $39.4 million in Q3 2025, and down 51.98% YoY from $85.0 million in Q4 2024.
ImageneBio (IMA) Short-term Investments (2022 - 2025) Analysis & Trends
ImageneBio has reported Short-term Investments for 4 years, with the latest figure at $40.8 million in Q4 2025.
- Quarterly Short-term Investments fell 51.98% year-over-year to $40.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.8 million (down 51.98% YoY) and the FY2025 annual result came in at $40.8 million, down 51.98% from the prior year.
- Short-term Investments improved to $40.8 million in Q4 2025 per IMA's latest filing, from $39.4 million in the prior quarter.
- Over five years, Short-term Investments peaked at $165.5 million in Q1 2022 and troughed at $37.4 million in Q2 2025.
- A 4-year average of $88.7 million and a median of $89.6 million in 2023 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2024 and 2025: Short-term Investments jumped 52.94% in 2024, then tumbled 63.07% in 2025.
- Over 4 years, Short-term Investments stood at $97.0 million in 2022, then sank by 42.73% to $55.6 million in 2023, then surged by 52.94% to $85.0 million in 2024, then slumped by 51.98% to $40.8 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $40.8 million, $39.4 million, and $37.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.82 Mn |
| Sep 30, 2025 | 39.42 Mn |
| Jun 30, 2025 | 37.35 Mn |
| Mar 31, 2025 | 77.29 Mn |
| Dec 31, 2024 | 84.99 Mn |
| Sep 30, 2024 | 92.84 Mn |
| Jun 30, 2024 | 101.15 Mn |
| Mar 31, 2024 | 104.50 Mn |
| Dec 31, 2023 | 55.57 Mn |
| Sep 30, 2023 | 75.66 Mn |
| Jun 30, 2023 | 86.44 Mn |
| Mar 31, 2023 | 108.48 Mn |
| Dec 31, 2022 | 97.03 Mn |
| Sep 30, 2022 | 107.29 Mn |
| Jun 30, 2022 | 144.32 Mn |
| Mar 31, 2022 | 165.50 Mn |